CLOVIS RAYMOND: Open Payments
NPI 1902034051 · BARDONIA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,779 in 97 payments from 13 companies in 2025. Trend: 2023 $1,186 · 2024 $1,371 · 2025 $2,779
Food & beverage: $2,700Education: $80
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $547 |
| Alkermes, Inc. | 16 | $460 |
| Janssen Pharmaceuticals, Inc | 13 | $455 |
| ABBVIE INC. | 19 | $366 |
| Lundbeck LLC | 10 | $210 |
| Otsuka America Pharmaceutical, Inc. | 3 | $166 |
| Axsome Therapeutics, Inc. | 7 | $158 |
| Teva Pharmaceuticals USA, Inc. | 3 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $99 |
| Collegium Pharmaceutical, Inc. | 3 | $71 |
Products named: COBENFY, INVEGA SUSTENNA, VRAYLAR, ARISTADA, ABILIFY MAINTENA, Auvelity, LYBALVI, CAPLYTA.
Industry payments across NY — which companies pay providers there.
